Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 31, 2016
Recipharm, the contract development and manufacturing organization (CDMO), has entered into a long term supply agreement with Tillotts Pharma AG.
read more
Wednesday, October 08, 2025
Recipharm has designated its Cuxhaven, Germany facility as a Centre of Excellence for analytical services supporting advanced therapy medicinal products (ATMPs) and biologics. The site now operates 500 m² of CGMP-compliant laboratories designed to ...
read more
Wednesday, December 20, 2023
Veeva Systems has revealed that Recipharm, a prominent global contract development and manufacturing organization (CDMO), will optimize its quality operations using Veeva Vault QMS, Veeva Vault QualityDocs, and Veeva Vault Training.
read more
Wednesday, March 14, 2012
Recipharm and ViroPharma today signed a commercial contract to initiate supply of Plenadren® for named patient use. In addition, ViroPharma are investing in capital equipment at the Recipharm manufacturing site - enabling large scale manufacturing ...
read more
Recipharm announces it will continue the manufacturing operations at its facility in Höganäs, Sweden, operations that earlier were set towards being discontinued.
read more
Recipharm, a leading global contract development and manufacturing organisation (CDMO), today announces the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics.
read more
Tuesday, February 21, 2017
Recipharm AB has now concluded the acquisition of Kemwell’s pharmaceutical businesses located in Bengaluru, India.
read more
Wednesday, March 14, 2018
Recipharm announces its new blow-fill-seal machinery is now operational following an investment last year at its facility in Kaysersberg, France.
read more
The contract development and manufacturing organization, Recipharm AB has completed the acquisition of a majority stake in Nitin Lifesciences Limited, an Indian sterile injectables CMO, currently owned by the Sobti family.
read more
Recipharm and Sanofi have completed the acquisition of Sanofi’s inhalation contract manufacturing business including a manufacturing facility located in Holmes Chapel, UK.
read more
Wednesday, October 26, 2022
Global contract development and manufacturing organization (CDMO) Recipharm, has bolstered its sterile filling capabilities by investing in Lab+ technology for low volume blow-fill-seal (BFS) filling at its facility in Kaysersberg, France.
read more
Friday, December 01, 2017
Recipharm AB announces that it has commenced the supply of commercial products to Roche and completed the acquisition of the manufacturing facility located in Spain.
read more
Wednesday, March 27, 2024
Recipharm, a global leader in contract development and manufacturing, has announced two major milestones as part of its ongoing commitment to sustainability, underpinning the Group’s pledge to minimize its environmental impact.
read more
Wednesday, February 14, 2018
Recipharm has appointed Bernard Pluta to lead its new global development organization.
read more
Recipharm has appointed Ann Flodin as General Manager of its wholly owned new subsidiary Recipharm Laboratories Inc. in Research Triangle Park, North Carolina, USA, formerly Cirrus Pharmaceuticals Inc.
read more